Axial Therapeutics™ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. 

Biotechnology

Axial Therapeutics

Axial Therapeutics' headquarters in Waltham, MA, United States

A. Stewart Campbell

Becca Senter

Eric De La Fortelle

Sakae Asanuma

Jim Blair

Rich Aldrich

Scott C. Brun

Sarkis Mazmanian

Ronald C. Renaud

Sarah Meibusch

The Research and Development team at Axial Therapeutics™ is dedicated to the discovery and development of gut-restricted, small molecule therapeutics targeting central nervous system (CNS) disorders. The team encompasses a range of roles from preclinical research and development to clinical study management and formulation manufacturing, working collaboratively to advance innovative therapeutic solutions from initial concept through to clinical trials.

Research and Development

The Leadership Team at Axial Therapeutics drives the strategic vision and operational direction of the company, overseeing the development of innovative therapeutics targeting CNS disorders. Comprising executives with expertise in research, development, and science, this team fosters collaboration across disciplines to advance clinical initiatives and ensure the successful translation of scientific discoveries into therapeutic solutions.

Axial Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Axial Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Related companies